{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,10]],"date-time":"2025-09-10T21:36:18Z","timestamp":1757540178413},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[1983,2,1]],"date-time":"1983-02-01T00:00:00Z","timestamp":412905600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Endocrinol Invest"],"published-print":{"date-parts":[[1983,2]]},"DOI":"10.1007\/bf03350556","type":"journal-article","created":{"date-parts":[[2014,4,10]],"date-time":"2014-04-10T23:15:35Z","timestamp":1397171735000},"page":"23-27","source":"Crossref","is-referenced-by-count":31,"title":["Antiandrogenic properties of spironolactone. Clinical trial in the management of female hirsutism"],"prefix":"10.1007","volume":"6","author":[{"given":"M.","family":"Messina","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Manieri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Biffignandi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Massucchetti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R. F.","family":"Novi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G. M.","family":"Molinatti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,4,11]]},"reference":[{"key":"BF03350556_CR1","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/BF00498838","volume":"296","author":"U Abshagen","year":"1976","unstructured":"Abshagen U., Rennekamp H., Luszinski G. Pharmacokinetics of spironolactone in man. Naunyn- Schmiedeberg\u2019s. Archives Pharmacology 296: 37, 1976.","journal-title":"Archives Pharmacology"},{"key":"BF03350556_CR2","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1210\/endo-103-4-1313","volume":"103","author":"JW Greiner","year":"1978","unstructured":"Greiner J.W., Rumbaugh R.C., Kramer R.E., Colby H.D. Relations of canrenone to the actions of spironolactone on adrenal cytochrome P-450 dependent enzymes. Endocrinology 103:1313, 1978.","journal-title":"Endocrinology"},{"key":"BF03350556_CR3","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1210\/endo-99-4-1097","volume":"99","author":"S Chiau-Cheng","year":"1976","unstructured":"Chiau-Cheng S., Suzuki K., Sadee W., Harding B.W. Effect of spironolactone, canrenone and K-canrenoate on cytochrome P-450 and 11\u03b2-and 18-hydroxylation in bovine and human adrenal cortical mytochondria. Endocrinology 99:1097, 1976.","journal-title":"Endocrinology"},{"key":"BF03350556_CR4","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1210\/jcem-47-3-691","volume":"47","author":"HP Shane","year":"1978","unstructured":"Shane H.P., Potts G.O. Oral progestational activity of spironolactone. J. Clin, Endocrinol. Metab. 47: 691, 1978.","journal-title":"J. Clin, Endocrinol. Metab."},{"key":"BF03350556_CR5","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1210\/jcem-44-6-1190","volume":"44","author":"U Abshagen","year":"1977","unstructured":"Abshagen U., Sporl S., Schoneshofer M., Oelkers W. Increased plasma 11 -deoxicorticosterone during spirono lactone medication. J. Clin. Endocrinol. Metab. 44:1190, 1977.","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BF03350556_CR6","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1210\/jcem-41-4-777","volume":"41","author":"B Stripp","year":"1975","unstructured":"Stripp B., Taylor A.A., Bartter F.C., Gilette J.R., Loriaux D.L, Easley R., Menard R.H. Effect of spironolactone on sex hormones in man. J. Clin. Endocrinol. Metab. 41: 111, 1975.","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BF03350556_CR7","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1111\/j.1365-2265.1978.tb01510.x","volume":"9","author":"A Miyatake","year":"1978","unstructured":"Miyatake A., Noma K, Nakao K., Moromoto Y., Yamamura Y. Increased serum oestrone and oestradiol following spironolactone administration in hypertensive men. Clin. Endocrinol. (Oxf.) 9: 523, 1978.","journal-title":"Clin. Endocrinol. (Oxf.)"},{"key":"BF03350556_CR8","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1111\/j.1365-2265.1978.tb03578.x","volume":"9","author":"MJ Tidd","year":"1978","unstructured":"Tidd M.J., Horth CE., Ramsay LE., Shelton J.R., Palmer R.F. Endocrine effects of spironolactone in man. Clin. Endocrinol. (Oxf.) 9: 389, 1978.","journal-title":"Clin. Endocrinol. (Oxf.)"},{"key":"BF03350556_CR9","first-page":"353","volume-title":"Endocrinological cancer: ovarian function and disease","author":"M Messina","year":"1980","unstructured":"Messina M., Biffignandi P., Manieri C., Ghigo E., Molinatti G.M. Spironolactone as an antiandrogen in the therapy of female hirsutism. In: Sciarra F., Bulbrook R.D., Adlercreuz H., Vermeulen H.A. (Eds.), Endocrinological cancer: ovarian function and disease. Excerpta Medica, Amsterdam, 1980, p. 353."},{"key":"BF03350556_CR10","volume-title":"Spironolactone therapy in female hirsutism","author":"M Messina","year":"1980","unstructured":"Messina M., Manieri C, Jeantet M.G., Biffignandi P., Ghigo E., Molinatti G.M. Spironolactone therapy in female hirsutism. Sixth International Congress of Endocrinology, Melbourne, February 5\u20138, 1980, (Abstract)."},{"key":"BF03350556_CR11","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1210\/jcem-45-2-255","volume":"45","author":"R Caminos-Torres","year":"1977","unstructured":"Caminos-Torres R., Ma L, Snyder P.J. Gynecomastia and semen abnormalities induced by spironolactone in normal men. J. Clin. Endocrinol. Metab. 45: 255, 1977.","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BF03350556_CR12","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1001\/jama.1973.03220280028007","volume":"225","author":"DS Greenblatt","year":"1973","unstructured":"Greenblatt D.S., Kock-Weser J. Adverse reactions to spironolactone. J.A.M.A. 225:40, 1973.","journal-title":"J.A.M.A."},{"key":"BF03350556_CR13","doi-asserted-by":"crossref","first-page":"2014","DOI":"10.1001\/jama.1970.03170120058015","volume":"221","author":"SL Levitt","year":"1970","unstructured":"Levitt S.L Spironolactone therapy and amenorrhoea. J.A.M.A. 221: 2014, 1970.","journal-title":"J.A.M.A."},{"key":"BF03350556_CR14","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1210\/endo-97-6-1521","volume":"97","author":"JV Pita","year":"1975","unstructured":"Pita J.V., Lippman M.E., Thompson E.B., Loriaux D.L. Interaction of spironolactone and digitalis with the 5\u03b1- dihydrotestosterone (DHT) receptor of rat ventral prostate. Endocrinology 97:1521, 1975.","journal-title":"Endocrinology"},{"key":"BF03350556_CR15","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1210\/jcem-46-2-338","volume":"46","author":"SM Rifka","year":"1977","unstructured":"Rifka S.M., Pita G.C., Vigersky R.A., Wilson Y.A., Loriaux D.L. Interactions of digitalis and spironolactone with human sex steroid receptors. J. Clin. Endocrinol. Metab. 46: 338, 1977.","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BF03350556_CR16","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/S0022-5347(17)67001-0","volume":"114","author":"PC Walsh","year":"1975","unstructured":"Walsh P.C., Siiteri P.K. Suppression of plasma androgens by spironolactone in castrated men with carcinoma of the prostate. J.Urol. 114:254, 1975.","journal-title":"J.Urol."},{"key":"BF03350556_CR17","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1210\/jcem-43-6-1386","volume":"43","author":"RJ Santen","year":"1976","unstructured":"Santen R.J., Kulin H.E., Loriaux D.L Spironolactone stimulation of gonadotropin secretion in boys with delayed adolescence. J. Clin. Endocrinol. Metab. 43:1386, 1976.","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BF03350556_CR18","first-page":"74","volume-title":"Spironolactone and female hirsutism","author":"M Messina","year":"1978","unstructured":"Messina M., Garione I., Molinatti G.M. Spironolactone and female hirsutism. Satellite Symposium of the VII International Congress of Pharmacology, Pharmacological Modulation of Steroid Action, Torino, July 23-25, 1978, p. 74 (Abstract)."},{"key":"BF03350556_CR19","first-page":"xxxii","volume":"5","author":"M Messina","year":"1979","unstructured":"Messina M., Biffignandi P., Manieri C, Ghigo E., Molinatti G.M. Spironolactone as an antiandrogen in the therapy of female hirsutism. J. Steroid Biochem. 5: xxxii, 1979, (Abstract).","journal-title":"J. Steroid Biochem."},{"key":"BF03350556_CR20","first-page":"840","volume":"26","author":"A Boiselle","year":"1978","unstructured":"Boiselle A. Clinical usefulness of spironolactone in the treatment of acne and hirsutism. Clin. Res. 26: 840, 1978.","journal-title":"Clin. Res."},{"key":"BF03350556_CR21","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/S0015-0282(16)44232-9","volume":"32","author":"A Boiselle","year":"1979","unstructured":"Boiselle A., Tremblay R.R. New therapeutic approach to the hirsute patient. Fertil. Steril. 32: 276, 1979.","journal-title":"Fertil. Steril."},{"key":"BF03350556_CR22","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1210\/jcem-51-3-429","volume":"51","author":"G Shapiro","year":"1980","unstructured":"Shapiro G., Evron S. A novel use of spironolactone: treatment of hirsutism. J. Clin. Endocrinol. Metab. 51: 429, 1980.","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BF03350556_CR23","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1210\/jcem-21-11-1440","volume":"21","author":"D Ferriman","year":"1961","unstructured":"Ferriman D., Gallwey J.D. Clinical assessment of body hair growth in women. J. Clin. Endocrinol. Metab. 21:1440, 1961.","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BF03350556_CR24","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1055\/s-0028-1111126","volume":"94","author":"J Hammerstein","year":"1969","unstructured":"Hammerstein J., Cupceancu B. Behandlung des Hirsutismus mit Cyproteronacetat. Dtsch. Med. Wochenschr. 94: 829, 1969.","journal-title":"Dtsch. Med. Wochenschr."},{"key":"BF03350556_CR25","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/0022-4731(75)90311-8","volume":"6","author":"J Hammerstein","year":"1975","unstructured":"Hammerstein J., Meckies J., Led-Rossberg I., Moltz L, Zielske F. Use of cyproterone acetate (CPA) in the treatment of acne, hirsutism and virilism. J. Steroid Biochem. 6: 827, 1975.","journal-title":"J. Steroid Biochem."},{"key":"BF03350556_CR26","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1210\/endo-94-6-1628","volume":"94","author":"RH Menard","year":"1974","unstructured":"Menard R.H., Stripp B., Gilette J.R. Spironolactone and testicular cytochrome P-450: decreased testosterone formation in several species and changes in hepatic drug metabolism. Endocrinology 94:1628, 1974.","journal-title":"Endocrinology"},{"key":"BF03350556_CR27","first-page":"297","volume-title":"Aldosterone antagonist in clinical medicine","author":"JF Dymling","year":"1978","unstructured":"Dymling J.F. The effect of spirolactone and spironolactone on plasma testosterone in man. In: Addison G.M., Asmussen N.W., Corvol P., Kloppernborg P.W.C., Norman N., Schroder R., Robertson J.I.C., (Eds.), Aldosterone antagonist in clinical medicine. Excerpta Medica, Amsterdam, 1978, p. 297."},{"key":"BF03350556_CR28","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1677\/joe.0.0840371","volume":"84","author":"J Lewy","year":"1980","unstructured":"Lewy J., Burshell A., Marbach M., Afflalo L, Glick S.M. Interactions of spironolactone with oestradiol receptors in cytosol. J. Endocrinol. 84:371, 1980.","journal-title":"J. Endocrinol."}],"container-title":["Journal of Endocrinological Investigation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03350556.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF03350556\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03350556","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,9]],"date-time":"2019-08-09T11:57:48Z","timestamp":1565351868000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF03350556"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1983,2]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[1983,2]]}},"alternative-id":["BF03350556"],"URL":"https:\/\/doi.org\/10.1007\/bf03350556","relation":{},"ISSN":["0391-4097","1720-8386"],"issn-type":[{"value":"0391-4097","type":"print"},{"value":"1720-8386","type":"electronic"}],"subject":[],"published":{"date-parts":[[1983,2]]}}}